The benefit of everolimus in recurrent/epithelioid angiosarcoma patients: Case reports and literature review
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.21832
Abstract: Epithelioid angiosarcoma (EA) is a kind of rare malignant soft tissue sarcoma, with high recurrence/metastatic rate and poor prognosis. To date, no effective standardized treatment regimen has been available for patients with recurrence/metastatic EA. Everolimus… read more here.
Keywords: recurrence metastatic; recurrent epithelioid; benefit everolimus; epithelioid angiosarcoma ... See more keywords